Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse CPE ELISA Kit (AC3273)
Cat.#: ASET-1862
Specifications
Description Mouse CPE ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse CPE concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.12 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2175 Human NKCC1 ELISA Kit (AC3586) Quantitative inquiry ASET-1486 Mouse beta MSH ELISA Kit (AC2897) Quantitative inquiry ASET-1480 Human GDF6 ELISA Kit (AC2891) Quantitative inquiry ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-1215 Human BDNF ELISA Kit (AC2626) Quantitative inquiry ASET-1320 Porcine Myelin Basic Protein ELISA Kit (AC2731) Quantitative inquiry ASET-1032 Human TrkC ELISA Kit (AC2443) Quantitative inquiry ASET-1261 Rat AKR7A2 ELISA Kit (AC2672) Quantitative inquiry ASET-1112 Human Neprilysin-2 ELISA Kit (AC2523) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket